Topical permethrin and oral ivermectin in the management of scabies: A prospective, randomized, double blind, controlled study
Open accessThe DOI matches its Crossref record.
Abstract
BACKGROUND: Scabies is a highly contagious and intensely pruritic parasitic infestation. It is a re-emerging infection in the new millennium especially with HIV pandemic and a significant health problem in developing countries. Various treatment modalities have been used since time immemorial but the search for an ideal scabicide is ongoing. AIMS: In this study, we compared the therapeutic efficacy of single application of topical 5% permethrin with oral ivermectin (200 μg/kg/dose) in a single-dose and a two-dose regimen in patients with scabies. METHODS: 120 clinically diagnosed cases of scabies (>5 years of age and/or >15 kg) were randomized into three treatment groups A, B, C of 40 patients each; receiving either topical 5% permethrin (group A) or oral ivermectin (200 μg/kg/dose) in a single dose (group B) or double dose regimen (group C) repeated at 2 weeks interval. Patients were followed up at 1, 2, and 4 weeks interval. At each visit, cure rate (>50% improvement in lesion count and pruritus and negative microscopy) was assessed and compared. RESULTS: Cure rate in three treatment groups at the end of 4 weeks was 94.7% (A), 90% (B), 89.7% (C), and thus all three treatment modalities were equally efficacious. However, at 1 week follow up, group A patients reported better improvement in both lesion count and pruritus. CONCLUSIONS: Both permethrin and ivermectin in both single and two dose regimen are equally efficacious and well tolerated in scabies. However, permethrin has a rapid onset of action.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Moxidectin and the avermectins: Consanguinity but not identity
Prichard, R., Ménez, C., & Lespine, A. (2012) · International Journal for Parasitology: Drugs and Drug Resistance · doi:10.1016/j.ijpddr.2012.04.001 · Cited by 439
“IVM has also proved efficacious for the treatment of strongyloidiasis and scabies in humans (Stepek et al., 2006; Sharma and Singal, 2011).”
MethodEuropean guideline for the management of scabies
Salavastru, C. M., Chosidow, O., Boffa, M. J., Janier, M., & Tiplica, G. S. (2017) · Journal of the European Academy of Dermatology and Venereology · doi:10.1111/jdv.14351 · Cited by 347
A Review of Scabies: An Infestation More than Skin Deep
Chandler, D. J., & Fuller, L. C. (2019) · Dermatology · doi:10.1159/000495290 · Cited by 259
Diagnosis, prevention, and treatment of scabies.
Shimose, L., & Munoz-Price, L. S. (2013) · Current Infectious Disease Reports · doi:10.1007/s11908-013-0354-0 · Cited by 50
Efficacy, acceptability and cost effectiveness of four therapeutic agents for treatment of scabies.
Abdel-Raheem, T. A., Méabed, E. M. H., Nasef, G. A., Abdel Wahed, W. Y., & Rohaim, R. M. A. (2016) · Journal of Dermatological Treatment · doi:10.3109/09546634.2016.1151855 · Cited by 30
Metadata
- Authors
- Singal, A., & Sharma, R.
- Venue
- Indian Journal of Dermatology, Venereology, and Leprology
- Publisher
- Scientific Scholar
- Published
- 2011
- Volume
- 77
- Issue
- 5
- Pages
- 581
- ISSN
- 0378-6323 (ISSN-L)
- OpenAlex
- W2018767908
- Cited by
- 67
- References
- 0
- FWCI
- 3.80
- Type
- journal article
- Language
- en
- Open access
- diamond
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Topical permethrin and oral ivermectin in the management of scabies: A prospective, randomized, double blind, controlled study. https://app.cochat.ai/papers/10.4103/0378-6323.84063
- The paper
- Singal, A., & Sharma, R. (2011). Topical permethrin and oral ivermectin in the management of scabies: A prospective, randomized, double blind, controlled study. Indian Journal of Dermatology, Venereology, and Leprology. https://doi.org/10.4103/0378-6323.84063
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.